Immediate Impact
65 standout
Citing Papers
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Works of Federico Oldoni being referenced
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Federico Oldoni | 132 | 157 | 89 | 110 | 13 | 340 | |
| Ester Ciociola | 138 | 163 | 67 | 144 | 13 | 375 | |
| G. Ballarini | 144 | 136 | 130 | 99 | 11 | 342 | |
| Mengdie Luo | 204 | 244 | 113 | 62 | 13 | 408 | |
| Erin Morgan | 63 | 123 | 71 | 72 | 17 | 323 | |
| Camilla Skoglund-Andersson | 89 | 172 | 127 | 62 | 8 | 363 | |
| Qianhua Fang | 114 | 157 | 58 | 107 | 15 | 363 | |
| Hovsep Mahdessian | 67 | 137 | 89 | 235 | 12 | 408 | |
| Yi-Ning Dai | 53 | 103 | 73 | 191 | 11 | 381 | |
| Pia Fahlbusch | 82 | 99 | 62 | 192 | 16 | 399 | |
| Jinghua Wang | 55 | 110 | 59 | 196 | 22 | 365 |
All Works
Login with ORCID to disown or claim papers
Loading papers...